Recent Research Information on Aplastic Anemia, MDS, and PNH

AA&MDSIF strives to keep patients, families, and hematology/oncology professionals up-to-date with developments in research and practice relevant to aplastic anemia, MDS and PNH. Shown below are recent articles from major hematology/oncology journals, retrieved from the National Library of Medicine’s PubMed portal to their MEDLINE database of journal citations and abstracts of the biomedical literature from around the world.


Looking for research oriented for patients and caregivers? For select reviews of important medical journal articles, written by hematology/oncology professionals, visit Research Reviews for Patients. These reviews interpret the most relevant information for patients from the latest published research.

Summary information is listed by publication date, title, journal title and senior author. By default, the articles are listed by their publication date in reverse chronological order, from the most recent article to oldest article. Clicking the date column heading will sort them the other way, from oldest to newest.

"Publication date" in most cases means when the article first appeared in the electronic/online issue of a journal, in advance of when it appears in the print journal. Keep in mind some articles may appear online months before appearing in print, and that some may be from online-only journals.

You can also alphabetically and reverse alphabetically sort articles, primary authors and journal titles by clicking their column heading. To find articles by disease type, choose it from the drop-down menu named "Filter by Disease", and only articles about those diseases will appear. The search box labeled “Filter by Search Term” lets you search for a word in the article title, author, or journal name.

When you open an article citation by clicking on the title, article summary information (this time including all authors) is again shown, and in most cases you can view the article abstract. In some cases the abstract is unavailable, and not shown. You can also progress to the article’s PubMed entry by clicking the PubMed ID number link, shown directly under the title. Here you can purchase the article for download viewing or view through your institutional library’s access. In some cases, full text viewing is free either from the publisher’s site or from PubMed Central, an searchable aggregation site of free full text articles.

The PubMed Web site has extensive features, along with help tools and links to other databases. Regular users are encouraged to become familiar with its many capabilities.

Publication Datesort icon Article Title Journal Title Primary Author Bone Marrow Disease(s)
01/01/2010 How much? How frequent? How long? A clinical guide to new therapies in myelodysplastic syndromes. Hematology Am Soc Hematol Educ Program Blum W. myelodysplastic syndromes (MDS)
01/01/2010 Lenalidomide in myelodysplastic syndromes: an erythropoiesis-stimulating agent or more? Curr Hematol Malig Rep Komrokji RS myelodysplastic syndromes (MDS)
01/01/2010 High-risk myelodysplastic syndromes: chemotherapy, transplantation, and beyond. Curr Hematol Malig Rep Gergis U myelodysplastic syndromes (MDS)
01/01/2010 Iron overload in myelodysplastic syndromes: diagnosis and management. Cancer Control List AF myelodysplastic syndromes (MDS)
01/01/2010 Myelodysplastic syndromes. Annu Rev Med Scott BL myelodysplastic syndromes (MDS)
01/01/2010 Myelodysplastic syndromes: a practical approach to diagnosis and treatment. Cleve Clin J Med Barzi A myelodysplastic syndromes (MDS)
01/01/2010 Decitabine in the treatment of myelodysplastic syndromes. Expert Rev Anticancer Ther Santos FP myelodysplastic syndromes (MDS)
01/05/2010 Successful bone marrow transplantation for children with aplastic anemia based on a best-available evidence strategy. Pediatr Transplant Okamoto Y aplastic anemia
02/05/2010 Prolonged survival with improved tolerability in higher-risk myelodysplastic syndromes: azacitidine compared with low dose ara-C. Br J Haematol Fenaux P myelodysplastic syndromes (MDS)
02/19/2010 Significance of JAK2 and TET2 mutations in myelodysplastic syndromes. Blood Rev Hellström-Lindberg E. myelodysplastic syndromes (MDS)